You have accessJournal of UrologyCME1 Apr 2023MP77-18 THE IMPACT OF TESTOSTERONE ON URINARY INCONTINENCE FOLLOWING ROBOT-ASSISTED LAPAROSCOPIC PROSTATECTOMY Jordan Kassab, John Lindsey Ii, Juan Torres-Anguiano, and Larry Lipshultz Jordan KassabJordan Kassab More articles by this author , John Lindsey IiJohn Lindsey Ii More articles by this author , Juan Torres-AnguianoJuan Torres-Anguiano More articles by this author , and Larry LipshultzLarry Lipshultz More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003351.18AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Urinary incontinence following robot-assisted laparoscopic prostatectomy (RALP) affects one in five men. Further, low testosterone has been associated with lower urinary tract symptoms and incontinence in both men and women. The aim of this study is to determine whether endogenous testosterone (T) levels (low or normal) or testosterone therapy (TTh) have an impact on the incidence of incontinence following RALP. METHODS: Utilizing diagnoses codes associated with RALP, 5129 patients were identified. We then retrospectively documented testosterone levels and continence status for each of these patients throughout the 10/1/2017 - 10/1/2022 observation period. The patient cohort was stratified into three groups: 1) eugonadal 2) hypogonadal and 3) patients on T therapy. Chi-squared analyses were used to determine associations between hypogonadism, eugonadism, TTh, and incontinence in patients who have undergone RALP. This work was completed on SPSS. RESULTS: Of the men with normal serum T (n=3972) who underwent RALP, 628 were found to have urinary incontinence (15.8 %) after one year. Of those men with hypogonadism who underwent RALP (n=656), 164 patients faced urinary incontinence (25.0%) after one year. Lastly, among the patients receiving TTh who had prostatectomies (n=501), 24 encountered incontinence (4.8%). There was a statistically significant difference of incontinence rates between the three patient populations (p<.00001). CONCLUSIONS: This study suggests that hypogonadal men undergoing RALP have an increased risk of urinary incontinence. These findings expand previously demonstrated associations between hypogonadism and less successful outcomes following oncologic genitourinary surgery. Further investigation of testosterone’s role in urinary continence following RALP may improve pre-operative evaluation and counseling as well as warrant new treatment paradigms for hypogonadal men with prostate cancer. Source of Funding: None © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 209Issue Supplement 4April 2023Page: e1109 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Jordan Kassab More articles by this author John Lindsey Ii More articles by this author Juan Torres-Anguiano More articles by this author Larry Lipshultz More articles by this author Expand All Advertisement PDF downloadLoading ...